Patent ID: 6335030
Filing Date: 2002-01-01
Classification: A61K,Y10S

Abstract:
Device for transdermal administration, characterized in that it administers dextromethorphan, (+)-3-methoxy-17-methyl-9&agr;,13&agr;,14&agr;-morphinan, or non-ionized prodrug or non-ionized metabolite thereof, together with a pharmaceutically acceptable carrier, to a human being or animal in order to achieve an antitussive effect, wherein the device has a loading of dextromethorphan of from about 0.1 mg/cm2 to about 10 mg/cm2 and an hourly flux rate of from about 1 &mgr;g/cm2/hour to about 100 &mgr;g/cm2/hour.